Clinical trial
Molecular Imaging of Primary Amyloid Cardiomyopathy
NCT02641145 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Imaging of Primary Amyloid Cardiomyopathy
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2016
- Completion date
- December 31, 2028
- Enrollment
- 171 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amyloidosis, primary, cardiomyopathy